Cohance Lifesciences Limited
COHANCE
株式のランク
#6395
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
株価
$5.05
最終同期: 2026-10-19
時価総額
$1.93B
変化（1日）
-1.44%
変化（1年）
-57.38%
国
IN
取引 Cohance Lifesciences Limited (COHANCE)
カテゴリー
Healthcare
Cohance Lifesciences Limited（COHANCE）の利益
Jun 2025 時点の利益 TTM: $37.76M
Cohance Lifesciences Limited の最新の財務報告によると、同社の現在の利益は $37.76M です。2024 年には $48.65M の利益を上げ、これは 2023 年の利益 $68.11M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Cohance Lifesciences Limited の利益の推移（2019 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $37.76M | -6.11% |
| 2025 | $40.21M | -17.35% |
| 2024 | $48.65M | -28.57% |
| 2023 | $68.11M | -22.55% |
| 2022 | $87.95M | 37.66% |
| 2021 | $63.89M | 18.98% |
| 2020 | $53.70M | 136.19% |
| 2019 | $22.73M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 4,573.48% |
IN
|
